<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Hemispherx Biopharma from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Hemispherx Biopharma news from BioPortfolio.com</description>
	<pubDate>Tue, 09 Feb 2010 19:36:26 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Hemispherx+Biopharma" rel="self" type="application/rss+xml" />

	
<item><title>New Animal Model for Evaluating Antiviral Agents Against the SARS Virus Indicates Potential Effect o</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4030949&amp;HITNO=0&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4030949&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533908764%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4030949&amp;HITNO=0&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4030949&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533908764%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Interest!ALERT:</description></item>
<item><title>New Animal Model for Evaluating Antiviral Agents Against the SARS Virus Indicates Potential Effect of Ampligen</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029712&amp;HITNO=1&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029712&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533240509%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029712&amp;HITNO=1&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029712&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533240509%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>Hemispherx Biopharma Appoints Two Senior Pharma Executives to Key...</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013662&amp;HITNO=2&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013662&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523799555%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013662&amp;HITNO=2&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013662&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523799555%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Zibb:</description></item>
<item><title>Hemispherx Biopharma Appoints Two Senior Pharma Executives to Key Manufacturing Positions</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013978&amp;HITNO=3&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013978&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523866191%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013978&amp;HITNO=3&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013978&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523866191%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>Hemispherx Biopharma Appoints Two Senior Pharma Executives to Key Manufacturing Positions</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013526&amp;HITNO=4&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013526&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523747547%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013526&amp;HITNO=4&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013526&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523747547%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Hemispherx Biopharma Appoints Two Senior Pharma Executives to Key Manufacturing Positions</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013479&amp;HITNO=5&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013479&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523730810%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013479&amp;HITNO=5&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013479&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523730810%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Hemispherx Biopharma Appoints Two Senior Pharma Executives to Key</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013393&amp;HITNO=6&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013393&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523711305%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013393&amp;HITNO=6&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013393&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523711305%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>GlobeNewswire via MSN Money:</description></item>
<item><title>Hemispherx Biopharma Appoints Two Senior Pharma Executives to Key Manufacturing Positions</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013570&amp;HITNO=7&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013570&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523760900%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013570&amp;HITNO=7&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013570&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523760900%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>GlobeNewswire via Yahoo!:</description></item>
<item><title>Hemispherx Biopharma Appoints Two Senior Pharma Executives to Key Manufacturing Positions</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013865&amp;HITNO=8&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013865&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523851011%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013865&amp;HITNO=8&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013865&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523851011%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Individual.com:</description></item>
<item><title>Hemispherx Biopharma Appoints Two Senior Pharma Executives to Key Manufacturing Positions</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013840&amp;HITNO=9&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013840&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523843192%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013840&amp;HITNO=9&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013840&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523843192%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>TradingMarkets:</description></item>
<item><title>Hemispherx Biopharma Appoints Two Senior Pharma Executives to Key Manufacturing Positions</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013626&amp;HITNO=10&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013626&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523783509%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013626&amp;HITNO=10&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013626&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523783509%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>PicksThatMove.com Announces Investment Opinion on Jura Energy Corporation, Blue Gem Enterprise, Coalcorp Mining Inc., Appleton Exploration Inc. and Hemispherx BioPharma Inc.</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4002155&amp;HITNO=11&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4002155&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2518771877%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4002155&amp;HITNO=11&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4002155&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2518771877%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>SmartBrief:</description></item>
<item><title>Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Amp</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3999539&amp;HITNO=12&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3999539&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517484556%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3999539&amp;HITNO=12&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3999539&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517484556%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Response</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3999117&amp;HITNO=13&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3999117&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517326902%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3999117&amp;HITNO=13&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3999117&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517326902%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>DMN Newswire:</description></item>
<item><title>Hemispherx Biopharma Receives Favorable Notice Via Its Subcontractor That the FDA Seattle District Accepts Ampligen(R) Manufacturing Response</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3999093&amp;HITNO=14&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3999093&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517319148%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3999093&amp;HITNO=14&amp;MSIZE=109&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Hemispherx%20Biopharma&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3999093&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517319148%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>DMN Newswire:</description></item>
</channel></rss>